Results 31 to 40 of about 13,790,477 (113)
The ADNP Syndrome and CP201 (NAP) Potential and Hope
Activity-dependent neuroprotective protein (ADNP) syndrome, also known as Helsmoortel-Van Der Aa syndrome, is a rare condition, which is diagnosed in children exhibiting signs of autism.
Illana Gozes
doaj +1 more source
ADNP is a regulator of the SWI/SNF chromatin remodelling complex. Abstract Background Autism spectrum disorder (ASD) affects approximately one in 59 children. Variants in the activity‐dependent neuroprotector homeobox ADNP (OMIM #611386) gene may be one of the most common single‐gene causes of syndromic ASD.
Amelle Shillington +3 more
wiley +1 more source
Abstract Introduction. Helsmoortel-Van der Aa syndrome (HVDAS) is a rare neurodevelopmental disorder caused by a mutation in the ADNP gene. Many previous studies concern the basis of the disease, but there is also a need to focus on the therapeutic aspect of people with HVDAS. Case presentation.
Aleksandra Mariola Kołecka +1 more
openaire +1 more source
ABSTRACT Mutations in ADNP (Activity-Dependent Neuroprotective Protein) are among the most frequent monogenic causes of autism spectrum disorder (ASD) and lead to Helsmoortel-Van der Aa syndrome (HVDAS). Yet how ADNP dysfunction leads to HVDAS is unclear. We employed patient-derived induced pluripotent stem cells, cortical organoids and
Rizzuti L +25 more
europepmc +2 more sources
Background ADNP syndrome is a rare Mendelian disorder characterized by global developmental delay, intellectual disability, and autism. It is caused by truncating mutations in ADNP, which is involved in chromatin regulation.
Eric G. Bend +23 more
doaj +1 more source
Autism spectrum disorder (ASD) is diagnosed after behavioral symptoms emerge, highlighting the need for early biological markers, such as brain scans, genetic profiles, and biological samples from blood and urine tests, that could predict ASD before symptoms develop.
Bonnie M. Wang +4 more
wiley +1 more source
Exome sequencing in every pregnancy? Results of trio exome sequencing in structurally normal fetuses
Abstract Objective This study aimed to assess the detection rate of clinically significant results of prenatal exome sequencing (pES) in low‐risk pregnancies and apparently normal fetuses in non‐consanguineous couples. Methods A retrospective analysis of pES conducted at a single center from January 2020 to September 2023 was performed.
Michal Levy +9 more
wiley +1 more source
Abstract With 50 years to the original discovery of Tau, I gave here my perspective, looking through the prism of activity‐dependent neuroprotective protein (ADNP), and the influence of sex. My starting point was vasoactive intestinal peptide (VIP), a regulator of ADNP. I then moved to the original discovery of ADNP and its active neuroprotective site,
Illana Gozes
wiley +1 more source
23rd Congress of the European Hematology Association Stockholm, Sweden, June 14‐17, 2018
HemaSphere, Volume 2, Issue S1, Page 1-1113, June 2018.
wiley +1 more source
et tout nouvellement mise en lumiere par Pierre van der Aa, marchand libraireTitel- und Massstabskartusche oben ...
Aa, Pieter van der
core +1 more source

